4//SEC Filing
Arbet-Engels Christophe 4
Accession 0001209191-20-008370
CIK 0001544227other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:02 PM ET
Size
5.6 KB
Accession
0001209191-20-008370
Insider Transaction Report
Form 4
Arbet-Engels Christophe
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2020-02-10+140,000→ 140,000 totalExercise: $6.90Exp: 2030-02-09→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on February 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the recipient continuing to provide service through that date.
Documents
Issuer
Millendo Therapeutics, Inc.
CIK 0001544227
Entity typeother
Related Parties
1- filerCIK 0001802615
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 5:02 PM ET
- Size
- 5.6 KB